- Home
- ACTU vs NRO Comparison
ACTU vs NRO Comparison
Compare ACTU & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- NRO
- Stock Information
- Founded
- ACTU 2015
- NRO 2003
- Country
- ACTU United States
- NRO United States
- Employees
- ACTU N/A
- NRO N/A
- Industry
- ACTU
- NRO Finance/Investors Services
- Sector
- ACTU
- NRO Finance
- Exchange
- ACTU NYSE
- NRO Nasdaq
- Market Cap
- ACTU 135.0M
- NRO 156.7M
- IPO Year
- ACTU 2024
- NRO N/A
- Fundamental
- Price
- ACTU $11.90
- NRO $3.24
- Analyst Decision
- ACTU Strong Buy
- NRO
- Analyst Count
- ACTU 1
- NRO 0
- Target Price
- ACTU $20.00
- NRO N/A
- AVG Volume (30 Days)
- ACTU 68.4K
- NRO 239.4K
- Earning Date
- ACTU 05-15-2025
- NRO 01-01-0001
- Dividend Yield
- ACTU N/A
- NRO 11.41%
- EPS Growth
- ACTU N/A
- NRO N/A
- EPS
- ACTU N/A
- NRO N/A
- Revenue
- ACTU N/A
- NRO N/A
- Revenue This Year
- ACTU N/A
- NRO N/A
- Revenue Next Year
- ACTU N/A
- NRO N/A
- P/E Ratio
- ACTU N/A
- NRO N/A
- Revenue Growth
- ACTU N/A
- NRO N/A
- 52 Week Low
- ACTU $5.51
- NRO $2.51
- 52 Week High
- ACTU $11.99
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- NRO 55.98
- Support Level
- ACTU N/A
- NRO $3.16
- Resistance Level
- ACTU N/A
- NRO $3.28
- Average True Range (ATR)
- ACTU 0.00
- NRO 0.06
- MACD
- ACTU 0.00
- NRO -0.00
- Stochastic Oscillator
- ACTU 0.00
- NRO 68.75
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").